N-{1-[2-(ethoxymethyl)-4-methyl-1,3-thiazol-5-yl]ethyl}ethene-1-sulfonamide
Structure Info
- Chemspace ID
- CSSB21332126722 (In-Stock Building Blocks)
- IUPAC Name
- N-{1-[2-(ethoxymethyl)-4-methyl-1,3-thiazol-5-yl]ethyl}ethene-1-sulfonamide
- Mol formula
- C11H18N2O3S2
- Mol weight
- 290 Da
- Catalog Number(s)
- BBLS21332126722, EN300-54826338, bbls21332126722
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 0.79
- Heavy atoms count
- 18
- Rotatable bond count
- 6
- Number of rings
- 1
- Carbon bond saturation, Fsp3
- 0.545
- Polar surface area (Å)
- 68
- Hydrogen bond acceptors count
- 4
- Hydrogen bond donors count
- 1
![Chemical structure of N-{1-[2-(ethoxymethyl)-4-methyl-1,3-thiazol-5-yl]ethyl}ethene-1-sulfonamide (C11H18N2O3S2) - CSSB21332126722](/st/structure/200/f8edc406072b32c74b16d158f2e5730a/CCOCC1%253DNC%2528C%2529%253DC%2528S1%2529C%2528C%2529NS%2528%253DO%2529%2528%253DO%2529C%253DC.png "C11H18N2O3S2")
- Zoom the structure
- CSSB21332126722
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 864.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 904.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 946.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 987.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 1,027.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 2,014.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 2,981.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 4,421.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of N-{1-[2-(ethoxymethyl)-4-methyl-1,3-thiazol-5-yl]ethyl}prop-2-enamide - CSSB01804894896](/st/structure/200/f1dd3856887e807a6359dd07f4268102/CCOCC1%253DNC%2528C%2529%253DC%2528S1%2529C%2528C%2529NC%2528%253DO%2529C%253DC.png)
![Chemical structure of N-[1-(2,4-dimethyl-1,3-thiazol-5-yl)ethyl]ethene-1-sulfonamide - CSSB00157170852](/st/structure/200/ba8d7b0baa6752c38acdd417b40d1795/CC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DC%2528C%2529N%253DC%2528C%2529S1.png)
![Chemical structure of N-{1-[5-(ethoxymethyl)-1,2,4-oxadiazol-3-yl]ethyl}ethene-1-sulfonamide - CSSB06835390633](/st/structure/200/ef038f31b646fbce702ce32cd4f53256/CCOCc1nc%2528no1%2529C%2528C%2529NS%2528%253DO%2529%2528%253DO%2529C%253DC.png)
![Chemical structure of N-[1-(4-methyl-2-phenyl-1,3-thiazol-5-yl)ethyl]ethene-1-sulfonamide - CSSB21332166255](/st/structure/200/d05c4850a0585ef6f4f0be4ef2130c40/CC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DC%2528C%2529N%253DC%2528S1%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of 2-chloro-N-{1-[2-(ethoxymethyl)-4-methyl-1,3-thiazol-5-yl]ethyl}acetamide - CSSB02389727819](/st/structure/200/139c28fd32c6632029affbe395271b3b/CCOCC1%253DNC%2528C%2529%253DC%2528S1%2529C%2528C%2529NC%2528%253DO%2529CCl.png)
